EpilepsyGTx gets $33M to test epilepsy gene therapy in Phase 1/2a

After more than two years of pitching investors, a London upstart with two current employees has pulled through with a $33 million Series A to see if it can crack into a relatively niche pocket …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registeration number 16808844